Steven George Lydeamore
Chief Executive OfficerMr. Steven George Lydeamore, also known as Steve, MBA, CPA, serves as Chief Executive Officer at Immuron Limited since June 27, 2022. He served as the Chief Executive Officer of Anatara Lifesciences Limited since December 2, 2018 until June 26, 2022. Mr. Lydeamore served as the Chief Financial Officer of Bionomics Limited since August 2017 until November 23, 2018. He served as President of Apobiologix. He served as the President of Global Specialty Pharma at Apotex Inc. since April 1, 2015. He served as Managing Director of International and Chief Business Officer of Apotex Inc. until April 1, 2015. He worked in various finance roles for F.H. Faulding & Co. Limited in Australia. He has international pharmaceutical experience. Mr. Lydeamore served as Chief Business Officer and Managing Director of International at Apotex Inc. until April 1, 2015. Mr. Lydeamore served as Vice President of Business Development for Americas at Mayne Pharma (USA) Inc. He was employed at Mayne Pharma (USA) Inc. He is a Certified Practising Accountant. He has a B.Bus. (Appl. Ec.) from Deakin University and MBA from RMIT University.
Positions
- Company NameImmuron LimitedStock CodeIMRNPositionChief Executive OfficerColleagues
- PBPaul BrennanIndependent Non-Executive Chairman
- JKJerry KanellosChief Scientific Officer
- FPFlavio PalumboChief Commercial Officer
- ALAaron LauritaChief Financial Officer
- DLDavid LyonHead of Marketing
- DPDaniel PollockIndependent Non-Executive Director
- DLDena LyrasMember of Advisory Board
- RSRavi SavarirayanIndependent Non-Executive Director
- GSGlenn S. TillotsonMember of Advisory Board
